Global Streptococcus Pneumoniae Vaccine Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 114
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- 7 -Valent

- 10 -Valent

- 13 -Valent

- 15 -Valent

- 23 -Valent

- Other

Segment by Application

- Children under 2 Years of Age

- Adults over 65 Years of Age

- Addicted Smokers Between the Ages of 19 and 64

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Pfizer

- Sanofi

- GSK

- Merck

- Eli Lilly

- AstraZeneca

- Abera

- S K Chemicals

- Beijing Minhai Biotechnology

- Baxter

- Biken

- Celgene Corporation

- Panacea Biotec

- Serum Institute of India

- Genentech

- Genocea Biosciences

- ImmunoBiology

- Lupin

- Nuron Biotech

- Biogen

- Valneva Austria

- Sinovac

Global Streptococcus Pneumoniae Vaccine Market Research Report 2022

Table of Contents
1 Streptococcus Pneumoniae Vaccine Market Overview
1.1 Product Overview and Scope of Streptococcus Pneumoniae Vaccine
1.2 Streptococcus Pneumoniae Vaccine Segment by Type
1.2.1 Global Streptococcus Pneumoniae Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 7 -Valent
1.2.3 10 -Valent
1.2.4 13 -Valent
1.2.5 15 -Valent
1.2.6 23 -Valent
1.2.7 Other
1.3 Streptococcus Pneumoniae Vaccine Segment by Application
1.3.1 Global Streptococcus Pneumoniae Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Children under 2 Years of Age
1.3.3 Adults over 65 Years of Age
1.3.4 Addicted Smokers Between the Ages of 19 and 64
1.3.5 Other
1.4 Global Streptococcus Pneumoniae Vaccine Market Size Estimates and Forecasts
1.4.1 Global Streptococcus Pneumoniae Vaccine Revenue 2017-2028
1.4.2 Global Streptococcus Pneumoniae Vaccine Sales 2017-2028
1.4.3 Streptococcus Pneumoniae Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Streptococcus Pneumoniae Vaccine Market Competition by Manufacturers
2.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Streptococcus Pneumoniae Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Streptococcus Pneumoniae Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Streptococcus Pneumoniae Vaccine Market Competitive Situation and Trends
2.5.1 Streptococcus Pneumoniae Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Streptococcus Pneumoniae Vaccine Players Market Share by Revenue
2.5.3 Global Streptococcus Pneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Streptococcus Pneumoniae Vaccine Retrospective Market Scenario by Region
3.1 Global Streptococcus Pneumoniae Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Streptococcus Pneumoniae Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
3.3.1 North America Streptococcus Pneumoniae Vaccine Sales by Country
3.3.2 North America Streptococcus Pneumoniae Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
3.4.1 Europe Streptococcus Pneumoniae Vaccine Sales by Country
3.4.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Streptococcus Pneumoniae Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Streptococcus Pneumoniae Vaccine Sales by Region
3.5.2 Asia Pacific Streptococcus Pneumoniae Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
3.6.1 Latin America Streptococcus Pneumoniae Vaccine Sales by Country
3.6.2 Latin America Streptococcus Pneumoniae Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Streptococcus Pneumoniae Vaccine Sales by Country
3.7.2 Middle East and Africa Streptococcus Pneumoniae Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Streptococcus Pneumoniae Vaccine Historic Market Analysis by Type
4.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Streptococcus Pneumoniae Vaccine Price by Type (2017-2022)
5 Global Streptococcus Pneumoniae Vaccine Historic Market Analysis by Application
5.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Streptococcus Pneumoniae Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Streptococcus Pneumoniae Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Sanofi Streptococcus Pneumoniae Vaccine Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 GSK Streptococcus Pneumoniae Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Streptococcus Pneumoniae Vaccine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Eli Lilly Streptococcus Pneumoniae Vaccine Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 AstraZeneca Streptococcus Pneumoniae Vaccine Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Abera
6.6.1 Abera Corporation Information
6.6.2 Abera Description and Business Overview
6.6.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Abera Streptococcus Pneumoniae Vaccine Product Portfolio
6.7.5 Abera Recent Developments/Updates
6.8 S K Chemicals
6.8.1 S K Chemicals Corporation Information
6.8.2 S K Chemicals Description and Business Overview
6.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 S K Chemicals Streptococcus Pneumoniae Vaccine Product Portfolio
6.8.5 S K Chemicals Recent Developments/Updates
6.9 Beijing Minhai Biotechnology
6.9.1 Beijing Minhai Biotechnology Corporation Information
6.9.2 Beijing Minhai Biotechnology Description and Business Overview
6.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Portfolio
6.9.5 Beijing Minhai Biotechnology Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Corporation Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Baxter Streptococcus Pneumoniae Vaccine Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 Biken
6.11.1 Biken Corporation Information
6.11.2 Biken Streptococcus Pneumoniae Vaccine Description and Business Overview
6.11.3 Biken Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Biken Streptococcus Pneumoniae Vaccine Product Portfolio
6.11.5 Biken Recent Developments/Updates
6.12 Celgene Corporation
6.12.1 Celgene Corporation Corporation Information
6.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Description and Business Overview
6.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Celgene Corporation Streptococcus Pneumoniae Vaccine Product Portfolio
6.12.5 Celgene Corporation Recent Developments/Updates
6.13 Panacea Biotec
6.13.1 Panacea Biotec Corporation Information
6.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Description and Business Overview
6.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Panacea Biotec Streptococcus Pneumoniae Vaccine Product Portfolio
6.13.5 Panacea Biotec Recent Developments/Updates
6.14 Serum Institute of India
6.14.1 Serum Institute of India Corporation Information
6.14.2 Serum Institute of India Streptococcus Pneumoniae Vaccine Description and Business Overview
6.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Serum Institute of India Streptococcus Pneumoniae Vaccine Product Portfolio
6.14.5 Serum Institute of India Recent Developments/Updates
6.15 Genentech
6.15.1 Genentech Corporation Information
6.15.2 Genentech Streptococcus Pneumoniae Vaccine Description and Business Overview
6.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Genentech Streptococcus Pneumoniae Vaccine Product Portfolio
6.15.5 Genentech Recent Developments/Updates
6.16 Genocea Biosciences
6.16.1 Genocea Biosciences Corporation Information
6.16.2 Genocea Biosciences Streptococcus Pneumoniae Vaccine Description and Business Overview
6.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Portfolio
6.16.5 Genocea Biosciences Recent Developments/Updates
6.17 ImmunoBiology
6.17.1 ImmunoBiology Corporation Information
6.17.2 ImmunoBiology Streptococcus Pneumoniae Vaccine Description and Business Overview
6.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.17.4 ImmunoBiology Streptococcus Pneumoniae Vaccine Product Portfolio
6.17.5 ImmunoBiology Recent Developments/Updates
6.18 Lupin
6.18.1 Lupin Corporation Information
6.18.2 Lupin Streptococcus Pneumoniae Vaccine Description and Business Overview
6.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Lupin Streptococcus Pneumoniae Vaccine Product Portfolio
6.18.5 Lupin Recent Developments/Updates
6.19 Nuron Biotech
6.19.1 Nuron Biotech Corporation Information
6.19.2 Nuron Biotech Streptococcus Pneumoniae Vaccine Description and Business Overview
6.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Nuron Biotech Streptococcus Pneumoniae Vaccine Product Portfolio
6.19.5 Nuron Biotech Recent Developments/Updates
6.20 Biogen
6.20.1 Biogen Corporation Information
6.20.2 Biogen Streptococcus Pneumoniae Vaccine Description and Business Overview
6.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Biogen Streptococcus Pneumoniae Vaccine Product Portfolio
6.20.5 Biogen Recent Developments/Updates
6.21 Valneva Austria
6.21.1 Valneva Austria Corporation Information
6.21.2 Valneva Austria Streptococcus Pneumoniae Vaccine Description and Business Overview
6.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Valneva Austria Streptococcus Pneumoniae Vaccine Product Portfolio
6.21.5 Valneva Austria Recent Developments/Updates
6.22 Sinovac
6.22.1 Sinovac Corporation Information
6.22.2 Sinovac Streptococcus Pneumoniae Vaccine Description and Business Overview
6.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Sinovac Streptococcus Pneumoniae Vaccine Product Portfolio
6.22.5 Sinovac Recent Developments/Updates
7 Streptococcus Pneumoniae Vaccine Manufacturing Cost Analysis
7.1 Streptococcus Pneumoniae Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine
7.4 Streptococcus Pneumoniae Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Streptococcus Pneumoniae Vaccine Distributors List
8.3 Streptococcus Pneumoniae Vaccine Customers
9 Streptococcus Pneumoniae Vaccine Market Dynamics
9.1 Streptococcus Pneumoniae Vaccine Industry Trends
9.2 Streptococcus Pneumoniae Vaccine Market Drivers
9.3 Streptococcus Pneumoniae Vaccine Market Challenges
9.4 Streptococcus Pneumoniae Vaccine Market Restraints
10 Global Market Forecast
10.1 Streptococcus Pneumoniae Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Streptococcus Pneumoniae Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Streptococcus Pneumoniae Vaccine by Type (2023-2028)
10.2 Streptococcus Pneumoniae Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Streptococcus Pneumoniae Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Streptococcus Pneumoniae Vaccine by Application (2023-2028)
10.3 Streptococcus Pneumoniae Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Streptococcus Pneumoniae Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Streptococcus Pneumoniae Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Streptococcus Pneumoniae Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Streptococcus Pneumoniae Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Streptococcus Pneumoniae Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Streptococcus Pneumoniae Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Streptococcus Pneumoniae Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Streptococcus Pneumoniae Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Streptococcus Pneumoniae Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Streptococcus Pneumoniae Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Streptococcus Pneumoniae Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Streptococcus Pneumoniae Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Streptococcus Pneumoniae Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Streptococcus Pneumoniae Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022) & (K Units)
Table 16. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)
Table 20. North America Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Streptococcus Pneumoniae Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Streptococcus Pneumoniae Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Streptococcus Pneumoniae Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Streptococcus Pneumoniae Vaccine Sales (K Units) by Application (2017-2022)
Table 45. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Streptococcus Pneumoniae Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Streptococcus Pneumoniae Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Streptococcus Pneumoniae Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer Streptococcus Pneumoniae Vaccine Product
Table 53. Pfizer Recent Developments/Updates
Table 54. Sanofi Corporation Information
Table 55. Sanofi Description and Business Overview
Table 56. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Sanofi Streptococcus Pneumoniae Vaccine Product
Table 58. Sanofi Recent Developments/Updates
Table 59. GSK Corporation Information
Table 60. GSK Description and Business Overview
Table 61. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. GSK Streptococcus Pneumoniae Vaccine Product
Table 63. GSK Recent Developments/Updates
Table 64. Merck Corporation Information
Table 65. Merck Description and Business Overview
Table 66. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Merck Streptococcus Pneumoniae Vaccine Product
Table 68. Merck Recent Developments/Updates
Table 69. Eli Lilly Corporation Information
Table 70. Eli Lilly Description and Business Overview
Table 71. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Eli Lilly Streptococcus Pneumoniae Vaccine Product
Table 73. Eli Lilly Recent Developments/Updates
Table 74. AstraZeneca Corporation Information
Table 75. AstraZeneca Description and Business Overview
Table 76. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. AstraZeneca Streptococcus Pneumoniae Vaccine Product
Table 78. AstraZeneca Recent Developments/Updates
Table 79. Abera Corporation Information
Table 80. Abera Description and Business Overview
Table 81. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Abera Streptococcus Pneumoniae Vaccine Product
Table 83. Abera Recent Developments/Updates
Table 84. S K Chemicals Corporation Information
Table 85. S K Chemicals Description and Business Overview
Table 86. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. S K Chemicals Streptococcus Pneumoniae Vaccine Product
Table 88. S K Chemicals Recent Developments/Updates
Table 89. Beijing Minhai Biotechnology Corporation Information
Table 90. Beijing Minhai Biotechnology Description and Business Overview
Table 91. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product
Table 93. Beijing Minhai Biotechnology Recent Developments/Updates
Table 94. Baxter Corporation Information
Table 95. Baxter Description and Business Overview
Table 96. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Baxter Streptococcus Pneumoniae Vaccine Product
Table 98. Baxter Recent Developments/Updates
Table 99. Biken Corporation Information
Table 100. Biken Description and Business Overview
Table 101. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Biken Streptococcus Pneumoniae Vaccine Product
Table 103. Biken Recent Developments/Updates
Table 104. Celgene Corporation Corporation Information
Table 105. Celgene Corporation Description and Business Overview
Table 106. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Celgene Corporation Streptococcus Pneumoniae Vaccine Product
Table 108. Celgene Corporation Recent Developments/Updates
Table 109. Panacea Biotec Corporation Information
Table 110. Panacea Biotec Description and Business Overview
Table 111. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Panacea Biotec Streptococcus Pneumoniae Vaccine Product
Table 113. Panacea Biotec Recent Developments/Updates
Table 114. Serum Institute of India Corporation Information
Table 115. Serum Institute of India Description and Business Overview
Table 116. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Serum Institute of India Streptococcus Pneumoniae Vaccine Product
Table 118. Serum Institute of India Recent Developments/Updates
Table 119. Genentech Corporation Information
Table 120. Genentech Description and Business Overview
Table 121. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Genentech Streptococcus Pneumoniae Vaccine Product
Table 123. Genentech Recent Developments/Updates
Table 124. Genocea Biosciences Corporation Information
Table 125. Genocea Biosciences Description and Business Overview
Table 126. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Genocea Biosciences Streptococcus Pneumoniae Vaccine Product
Table 128. Genocea Biosciences Recent Developments/Updates
Table 129. ImmunoBiology Corporation Information
Table 130. ImmunoBiology Description and Business Overview
Table 131. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. ImmunoBiology Streptococcus Pneumoniae Vaccine Product
Table 133. ImmunoBiology Recent Developments/Updates
Table 134. Lupin Corporation Information
Table 135. Lupin Description and Business Overview
Table 136. Lupin Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Lupin Streptococcus Pneumoniae Vaccine Product
Table 138. Lupin Recent Developments/Updates
Table 139. Nuron Biotech Corporation Information
Table 140. Nuron Biotech Description and Business Overview
Table 141. Nuron Biotech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Nuron Biotech Streptococcus Pneumoniae Vaccine Product
Table 143. Nuron Biotech Recent Developments/Updates
Table 144. Biogen Corporation Information
Table 145. Biogen Description and Business Overview
Table 146. Biogen Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Biogen Streptococcus Pneumoniae Vaccine Product
Table 148. Biogen Recent Developments/Updates
Table 149. Valneva Austria Corporation Information
Table 150. Valneva Austria Description and Business Overview
Table 151. Valneva Austria Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Valneva Austria Streptococcus Pneumoniae Vaccine Product
Table 153. Valneva Austria Recent Developments/Updates
Table 154. Sinovac Corporation Information
Table 155. Sinovac Description and Business Overview
Table 156. Sinovac Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Sinovac Streptococcus Pneumoniae Vaccine Product
Table 158. Sinovac Recent Developments/Updates
Table 159. Production Base and Market Concentration Rate of Raw Material
Table 160. Key Suppliers of Raw Materials
Table 161. Streptococcus Pneumoniae Vaccine Distributors List
Table 162. Streptococcus Pneumoniae Vaccine Customers List
Table 163. Streptococcus Pneumoniae Vaccine Market Trends
Table 164. Streptococcus Pneumoniae Vaccine Market Drivers
Table 165. Streptococcus Pneumoniae Vaccine Market Challenges
Table 166. Streptococcus Pneumoniae Vaccine Market Restraints
Table 167. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 168. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 169. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 170. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 171. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 172. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 173. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 174. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 175. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 176. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 177. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 178. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Streptococcus Pneumoniae Vaccine
Figure 2. Global Streptococcus Pneumoniae Vaccine Market Share by Type in 2021 & 2028
Figure 3. 7 -Valent Product Picture
Figure 4. 10 -Valent Product Picture
Figure 5. 13 -Valent Product Picture
Figure 6. 15 -Valent Product Picture
Figure 7. 23 -Valent Product Picture
Figure 8. Other Product Picture
Figure 9. Global Streptococcus Pneumoniae Vaccine Market Share by Application in 2021 & 2028
Figure 10. Children under 2 Years of Age
Figure 11. Adults over 65 Years of Age
Figure 12. Addicted Smokers Between the Ages of 19 and 64
Figure 13. Other
Figure 14. Global Streptococcus Pneumoniae Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Streptococcus Pneumoniae Vaccine Market Size (2017-2028) & (US$ Million)
Figure 16. Global Streptococcus Pneumoniae Vaccine Sales (2017-2028) & (K Units)
Figure 17. Streptococcus Pneumoniae Vaccine Sales Share by Manufacturers in 2021
Figure 18. Global Streptococcus Pneumoniae Vaccine Revenue Share by Manufacturers in 2021
Figure 19. The Global 5 and 10 Largest Streptococcus Pneumoniae Vaccine Players: Market Share by Revenue in 2021
Figure 20. Streptococcus Pneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2022)
Figure 22. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Region in 2021
Figure 23. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2017-2022)
Figure 24. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Region in 2021
Figure
  • Global Ayurvedic Suppressant Drugs Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 102
    This report aims to provide a comprehensive presentation of the global market for Ayurvedic Suppressant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ayurvedic Suppressant Drugs. The Ayurvedic Suppressant Drugs market size, estimations, and forecasts are provided in terms of sales volume (K ......
  • Global Children's Vitamin Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 114
    This report aims to provide a comprehensive presentation of the global market for Children's Vitamin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children's Vitamin. The Children's Vitamin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ milli......
  • Global Vegan Kids Vitamin Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 107
    This report aims to provide a comprehensive presentation of the global market for Vegan Kids Vitamin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vegan Kids Vitamin. The Vegan Kids Vitamin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ milli......
  • Global Radiation Dermatitis Cream Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 101
    This report aims to provide a comprehensive presentation of the global market for Radiation Dermatitis Cream, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiation Dermatitis Cream. The Radiation Dermatitis Cream market size, estimations, and forecasts are provided in terms of sales volume (K Uni......
  • Global Vegan Digestive Enzyme Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 113
    This report aims to provide a comprehensive presentation of the global market for Vegan Digestive Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vegan Digestive Enzyme. The Vegan Digestive Enzyme market size, estimations, and forecasts are provided in terms of sales volume (K Units) and reve......
  • Global Lung Cancer Vaccine Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 89
    This report aims to provide a comprehensive presentation of the global market for Lung Cancer Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Vaccine. The Lung Cancer Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ mi......
  • Global New Generation Cancer Vaccine Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 88
    This report aims to provide a comprehensive presentation of the global market for New Generation Cancer Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Generation Cancer Vaccine. The New Generation Cancer Vaccine market size, estimations, and forecasts are provided in terms of sales volu......
  • Global Valley Fever Medication Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 92
    This report aims to provide a comprehensive presentation of the global market for Valley Fever Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valley Fever Medication. The Valley Fever Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), co......
  • Global Activated Charcoal Dietary Supplements Market Research Report 2022
    Published: 10-Aug-2022        Price: US 2900 Onwards        Pages: 92
    This report aims to provide a comprehensive presentation of the global market for Activated Charcoal Dietary Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Activated Charcoal Dietary Supplements. The Activated Charcoal Dietary Supplements market size, estimations, and forecasts are prov......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs